Avaliação de corrimento vaginal

Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].Texto completo

Sherrard J, Wilson J, Donders G, et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018 Nov;29(13):1258-72. Resumo

Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024 Mar 5:ciae104.Texto completo  Resumo

1. Watson LJ, James KE, Hatoum Moeller IJ, et al. Vulvovaginal discomfort is common in both premenopausal and postmenopausal women. J Low Genit Tract Dis. 2019 Apr;23(2):164-9. Resumo

2. Foxman B, Marsh JV, Gillespie B, et al. Frequency and response to vaginal symptoms among white and African American women: Results of a random digit dialing survey. J Womens Health. 1998 Nov;7(9):1167-74. Resumo

3. Patel V, Pednekar S, Weiss H, et al. Why do women complain of vaginal discharge? A population survey of infectious and pyschosocial risk factors in a South Asian community. Int J Epidemiol. 2005 Aug;34(4):853-62.Texto completo  Resumo

4. Hillier SL, Austin M, Macio I, et al. Diagnosis and treatment of vaginal discharge syndromes in community practice settings. Clin Infect Dis. 2021 May 4;72(9):1538-43.Texto completo  Resumo

5. National Institute for Health and Care Excellence. Antenatal care. Aug 2021 [internet publication].Texto completo

6. da Fonseca TM, Cesar JA, Mendoza-Sassi RA, et al. Pathological vaginal discharge among pregnant women: pattern of occurrence and association in a population-based survey. Obstet Gynecol Int. 2013;2013:590416.Texto completo  Resumo

7. Prasad D, Parween S, Kumari K, et al. Prevalence, etiology, and associated symptoms of vaginal discharge during pregnancy in women seen in a tertiary care hospital in Bihar. Cureus. 2021 Jan 14;13(1):e12700.Texto completo  Resumo

8. Cesar JA, Mendoza-Sassi RA, González-Chica DA, et al. Prevalence of self-reported vaginal discharge and associated factors in pregnant women [in Portuguese]. Cad Saude Publica. 2009 Dec;25(12):2705-14.Texto completo  Resumo

9. Centers for Disease Control and Prevention. Sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].Texto completo

10. Mitchell H. Vaginal discharge-causes, diagnosis, and treatment. BMJ. 2004 May 29;328(7451):1306-8.Texto completo  Resumo

11. Sobel JD. Vulvovaginitis in healthy women. Compr Ther. 1999 Jun-Jul;25(6-7):335-46. Resumo

12. Sobel JD. Pathogenesis of recurrent vulvovaginal candidiasis. Curr Inf Dis Rep. 2002 Dec;4(6):514-9. Resumo

13. Goje O, Munoz JL. Vulvovaginitis: find the cause to treat it. Cleve Clin J Med. 2017 Mar;84(3):215-24.Texto completo  Resumo

14. Angelou K, Grigoriadis T, Diakosavvas M, et al. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020 Apr 8;12(4):e7586.Texto completo  Resumo

15. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007 Nov;34(11):864-9. Resumo

16. Hoffmann JN, You HM, Hedberg EC, et al. Prevalence of bacterial vaginosis and Candida among postmenopausal women in the United States. J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69 Suppl 2(suppl 2):S205-14.Texto completo  Resumo

17. Peebles K, Velloza J, Balkus JE, et al. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis. 2019 May;46(5):304-11. Resumo

18. Bautista CT, Wurapa E, Sateren WB, et al. Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res. 2016;3:4.Texto completo  Resumo

19. Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005 Nov 3;353(18):1899-911.Texto completo  Resumo

20. Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol. 1993 Aug;169(2 Pt 2):450-4. Resumo

21. Hay P. Recurrent bacterial vaginosis. Curr Infect Dis Rep. 2000 Dec;2(6):506-12. Resumo

22. Sobel JD, Kaur N, Woznicki NA, et al. Prognostic indicators of recurrence of bacterial vaginosis. J Clin Microbiol. 2019 May;57(5):e00227-19.Texto completo  Resumo

23. Schwebke J, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol. 2007 Jun;196(6):517;e1-6.Texto completo  Resumo

24. Peipert J, Montagno AB, Cooper AS, et al. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol. 1997 Nov;177(5):1184-7. Resumo

25. British Association for Sexual Health and HIV. UK National guideline for the management of bacterial vaginosis. 2012 [internet publication].Texto completo

26. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998 Sep 10;12(13):1699-706. Resumo

27. Sena AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007 Jan 1;44(1):13-22. Resumo

28. Vutyavanich T, Pongsuthirak P, Vannareumol P, et al. A randomized double-blind trial of tinidazole treatment of the sexual partners of females with bacterial vaginosis. Obstet Gynecol. 1993 Oct;82(4 Pt 1):550-4. Resumo

29. Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003 Jul;189(1):139-47. Resumo

30. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995 Dec 28;333(26):1737-42.Texto completo  Resumo

31. Brocklehurst P, Gordon A, Heatley E, et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000262.Texto completo  Resumo

32. Klebanoff MA, Schuit E, Lamont RF, et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: systematic review and individual participant data meta-analysis. Paediatr Perinat Epidemiol. 2023 Mar;37(3):239-51.Texto completo  Resumo

33. Kahwati LC, Clark R, Berkman N, et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2020 Apr 7;323(13):1293-1309.Texto completo  Resumo

34. Kahwati LC, Clark R, Berkman ND, et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr. Report No.: 19-05259-EF-1.Texto completo  Resumo

35. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004 Mar 17;291(11):1368-79. Resumo

36. Krieger JN. Urologic aspects of trichomoniasis. Invest Urol. 1981 May;18(8):411-7. Resumo

37. Sherrard J, Pitt R, Hobbs KR, et al. British Association for Sexual Health and HIV (BASHH) United Kingdom national guideline on the management of Trichomonas vaginalis 2021. Int J STD AIDS. 2022 Jul;33(8):740-50. Resumo

38. Sherrard J, Wilson J, Donders G, et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018 Nov;29(13):1258-72. Resumo

39. Røttingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001 Oct;28(10):579-97.Texto completo  Resumo

40. Wang CC, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis. 2001 Apr 1;183(7):1017-22.Texto completo  Resumo

41. Kissinger P, Amedee A, Clark RA, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009 Jan;36(1):11-6.Texto completo  Resumo

42. Sobel JD. Vaginal infections in adult women. Med Clin North Am. 1990 Nov;74(6):1573-602. Resumo

43. Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019 Mar 29;19(1):48.Texto completo  Resumo

44. Denning DW, Kneale M, Sobel JD, et al. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018 Nov;18(11):e339-47. Resumo

45. Ferris DG, Nyirjesy P, Sobel JD, et al. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002 Mar;99(3):419-25. Resumo

46. De Leon EM, Jacober SJ, Sobel JD, et al. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002 Jan 30;2:1. Resumo

47. National Institute for Health and Care Excellence. Candida - female genital: what are the risk factors? July 2022 [internet publication].Texto completo

48. Eckert LO, Hawes SE, Stevens CE, et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol. 1998 Nov;92(5):757-65. Resumo

49. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998 Feb;178(2):203-11.Texto completo  Resumo

50. Saxon Lead Author GDGC, Edwards A, Rautemaa-Richardson R, et al. British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019). Int J STD AIDS. 2020 Oct;31(12):1124-44.

51. Jensen JS, Cusini M, Gomberg M, et al. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022 May;36(5):641-50. Resumo

52. Sobel JD. Vaginitis. N Engl J Med. 1997 Dec 25;337(26):1896-903. Resumo

53. Verstraelen H, Verhelst R, Vaneechoutte M, et al. Group A streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women. Arch Gynecol Obstet. 2011 Jul;284(1):95-8. Resumo

54. Yirenya-Tawiah D, Amoah C, Apea-Kubi KA, et al. A survey of female genital schistosomiasis of the lower reproductive tract in the Volta basin of Ghana. Ghana Med J. 2011 Mar;45(1):16-21.Texto completo  Resumo

55. Foda AA, El-Malky MM. Prevalence of genital tract infection with Entamoeba gingivalis among copper T 380A intrauterine device users in Egypt. Contraception. 2012 Jan;85(1):108-12. Resumo

56. Bradbury RS, Roy S, Ali IK, et al. Case report: cervicovaginal co-colonization with Entamoeba gingivalis and Entamoeba polecki in association with an intrauterine device. Am J Trop Med Hyg. 2019 Feb;100(2):311-3.Texto completo  Resumo

57. Rodrigues AC, Teixeira R, Teixeira T, et al. Impact of pelvic radiotherapy on female sexuality. Arch Gynecol Obstet. 2012 Feb;285(2):505-14. Resumo

58. Bradford J, Fischer G. Desquamative inflammatory vaginitis: differential diagnosis and alternate diagnostic criteria. J Low Genit Tract Dis. 2010 Oct;14(4):306-10. Resumo

59. Baessler K, Hewson AD, Tunn R, et al. Severe mesh complications following intravaginal slingplasty. Obstet Gynecol. 2005 Oct;106(4):713-6. Resumo

60. US Food and Drug Administration. Urogynecologic surgical mesh implants. Aug 2021 [internet publication].Texto completo

61. US Food and Drug Administration. FDA's activities: urogynecologic surgical mesh. Oct 2022 [internet publication].Texto completo

62. NHS Improvement and NHS England. Vaginal mesh: high vigilance restriction period. Provider Bulletin. 11 Jul 2018 [internet publication].Texto completo

63. NHS Improvement and NHS England. Extension of pause on the use of vaginal mesh. 29 Mar 2019 [internet publication].Texto completo

64. Medicines and Healthcare products Regulatory Agency. Pause on the use of vaginally inserted surgical mesh for stress urinary incontinence. Jul 2018 [internet publication].Texto completo

65. NHS Resolution​. Vaginal mesh: what is a vaginal mesh implant? Oct 2022 [internet publication].Texto completo

66. Sanfilippo JS, Wakim NG. Bleeding and vulvovaginitis in the pediatric age group. Clin Obstet Gynecol. 1987 Sep;30(3):653-61. Resumo

67. McGreal S, Wood P. Recurrent vaginal discharge in children. J Pediatr Adolesc Gynecol. 2013 Aug;26(4):205-8. Resumo

68. Gao H, Zhang Y, Pan Y, et al. Patterns of pediatric and adolescent female genital inflammation in China: an eight-year retrospective study of 49,175 patients in China. Front Public Health. 2023;11:1073886.Texto completo  Resumo

69. Eyk NV, Allen L, Giesbrecht E, et al. Pediatric vulvovaginal disorders: a diagnostic approach and review of the literature. J Obstet Gynaecol Can. 2009 Sep;31(9):850-62. Resumo

70. Jaquiery A, Stylianopoulos A, Hogg G, et al. Vulvovaginitis: clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child. 1999 Jul;81(1):64-7.Texto completo  Resumo

71. Striegel AM, Myers JB, Sorensen MD, et al. Vaginal discharge and bleeding in girls younger than 6 years. J Urol. 2006 Dec;176(6 Pt 1):2632-5. Resumo

72. Simon DA, Berry S, Brannian J, et al. Recurrent, purulent vaginal discharge associated with longstanding presence of a foreign body and vaginal stenosis. J Pediatr Adolesc Gynecol. 2003 Dec;16(6):361-3. Resumo

73. Merkley K. Vulvovaginitis and vaginal discharge in the pediatric patient. J Emerg Nurs. 2005 Aug;31(4):400-2. Resumo

74. Singh RH, Zenilman JM, Brown KM, et al. The role of physical examination in diagnosing common causes of vaginitis: a prospective study. Sex Transm Infect. 2013 May;89(3):185-90. Resumo

75. Chinnock B, Yore M, Mason J, et al. Self-obtained vaginal swabs are not inferior to provider-performed endocervical sampling for emergency department diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis. Acad Emerg Med. 2021 Jun;28(6):612-20.Texto completo  Resumo

76. Barnes P, Vieira R, Harwood J, et al. Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care. Br J Gen Pract. 2017 Dec;67(665):e824-9.Texto completo  Resumo

77. Strauss RA, Eucker B, Savitz DA, et al. Diagnosis of bacterial vaginosis from self-obtained vaginal swabs. Infect Dis Obstet Gynecol. 2005 Mar;13(1):31-5.Texto completo  Resumo

78. Smith K, Harrington K, Wingood G, et al. Self-obtained vaginal swabs for diagnosis of treatable sexually transmitted diseases in adolescent girls. Arch Pediatr Adolesc Med. 2001 Jun;155(6):676-9.Texto completo  Resumo

79. Van Der Pol B, Williams JA, Taylor SN, et al. Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol. 2014 Mar;52(3):885-9.Texto completo  Resumo

80. Gaydos CA, Hsieh YH, Barnes M, et al. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment. Sex Transm Dis. 2011 Sep;38(9):828-32.Texto completo  Resumo

81. Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024 Mar 5:ciae104.Texto completo  Resumo

82. Coleman JS, Gaydos CA. Molecular diagnosis of bacterial vaginosis: an update. J Clin Microbiol. 2018 Sep;56(9):e00342-18.Texto completo  Resumo

83. Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019 Sep;30(10):938-50.Texto completo  Resumo

84. Phillips NA, Bachmann GA. Genitourinary syndrome of menopause: common problem, effective treatments. Cleve Clin J Med. 2018 May;85(5):390-8.Texto completo  Resumo

85. Carey FM, Quah SP, Hedderwick S, et al. Genital schistosomiasis. Int J STD AIDS. 2001 Sep;12(9):609-11. Resumo

86. Kleppa E, Holmen SD, Lillebø K, et al. Re: Al-Baghdadi O, Samarasinghe A, Wissa I. 2014. Cervical schistosomiasis. Journal of Obstetrics and Gynaecology 34:206. J Obstet Gynaecol. 2014;34(8):755-6. Resumo

87. Stott D, Zakaria M. The transcervical expulsion of a large fibroid. BMJ Case Reports. BMJ Case Rep. 2012 Sep 24;2012:bcr0120125523.Texto completo  Resumo

88. de la Poza G, López-Sanroman A, Taxonera C, et al. Genital fistulas in female Crohn's disease patients: clinical characteristics and response to therapy. J Crohns Colitis. 2012 Apr;6(3):276-80. Resumo

89. Smith Knutsson E, Björk Y, Broman AK, et al. A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment. Acta Obstet Gynecol Scand. 2018 Sep;97(9):1122-9.Texto completo  Resumo

90. Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet. 2009 May 2;373(9674):1550-61.Texto completo  Resumo

91. Bates S. Vaginal discharge​. Current Obstetrics & Gynaecology. 2003 Aug;13(4):218-23.

92. Ou YC, Huang HY, Huang CC, et al. Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases. Taiwan J Obstet Gynecol. 2011 Jun;50(2):141-4. Resumo

93. Cao XX, Li J, Zhang W, et al. Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse. Ann Hematol. 2014 Jun;93(6):1001-5. Resumo

94. Bull L, Knowles A, Ogden S, et al. Primary cervical lymphoma: a rare presentation to a genitourinary medicine clinic. Int J STD AIDS. 2013 Jul;24(7):587-9. Resumo

95. Mittal V, Jain A, Pradeep Y. Development of modified diagnostic criteria for bacterial vaginosis at peripheral health centres in developing countries. J Infect Dev Ctries. 2012 May 14;6(5):373-7. Resumo

96. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan;74(1):14-22. Resumo

97. Simoes JA, Discacciati MG, Brolazo EM, et al. Clinical diagnosis of bacterial vaginosis. Int J Gynaecol Obstet. 2006 Jul;94(1):28-32. Resumo

98. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014;63(RR-02):1-19.Texto completo  Resumo

99. Geisler WM, Chow JM, Schachter J, et al. Pelvic examination findings and Chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test. Sex Transm Dis. 2007 Jun;34(6):335-8. Resumo

100. Centers for Disease Control and Prevention. Genital herpes. Sexually transmitted infections treatment guidelines, 2021. Sep 2022 ​[internet publication].Texto completo

101. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet. 1990 May 5;335(8697):1078-80.Texto completo  Resumo

102. International Team for the Revision of the International Criteria for Behçet's Disease (ITR-ICBD). The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47. Resumo